Showing 221-230 of 8820 results for "".
DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-approves-humira-biosimilar-study-examines-trifarotene-acne-lesions/24513/In this episode of DermwireTV, the FDA approves a high-concentration Humira biosimilar; a study finds trifarotene combined with a skincare regimen was effective for acne-induced hyperpigmentation; the FDA accepts Dermavant's NDA for Vtama cream for AD; and the PA Perspective series addresses buildinPart 4, 1726 nm lasers: Handling referred patients who are already on different treatment regimens
https://practicaldermatology.com/series/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24342/Chapter 4 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about handling referred patients who are already on different treatment regimens.How Page Load Speed Impacts SEO And User Experience for a Dermatology Website
https://practicaldermatology.com/topics/practice-management/how-page-load-speed-impacts-seo-and-user-experience-for-a-dermatology-website/18968/This Ekwa educational video offers tips for improving your SEO ranking and your website visitor experience by ensuring optimum performance. Page load speeds are an important consideration when evaluating your dermatology practice website.Hoya ConBio - Vascular Lesions
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hoya-conbio-vascular-lesions/19454/Vascular Lesions that aren't successfully removed by other treatments are usually successfully removed with the Medlite Laser. Instructions and ideal settings for the laser are discussed.What’s the Latest in Hair Management?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/whats-the-latest-in-hair-management/20113/Chytra Anand, MD, Neil Sadick, MD, and Brooke Jackson, MD offer insights on the best approaches to managing hair from global clinical experience to strategies for understanding the needs of each individual patient, they share tips to improve clinical outcomes.Hair Loss in Patients With Diverse Skin Tones (Part 2)
https://practicaldermatology.com/programs/practical-dermatology/hair-loss-in-patients-with-diverse-skin-tones-part-2/18195/In this second installment of a two-part episode of The Practical Dermatology Podcast, Brooke Jackson, MD, founder and owner of Skin Wellness Dermatology Associates in Durham, NC, and a dermatologic surgeon and dermatologist, continues the conversation, focusing on different hair textures and stylesThe Latest in Hidradenitis Suppurativa (HS)
https://practicaldermatology.com/conferences/maui-derm-2024/the-latest-in-hidradenitis-suppurativa-hs/20251/Raj Chovatiya, MD, PhD, board-certified dermatologist and clinician investigator based in Chicago, discusses the incredible pipeline for Hidradenitis suppurativa (HS), as well as new and emerging treatment options.DermWireTV: Cosmetic Surgery Forum Highlights, LEO Focuses on AD
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cosmetic-surgery-forum-highlights-leo-focuses-on-ad/19703/New treatments and medical controversies take center stage at Cosmetic Surgery Forum as the meeting moves to Nashville in its 11th Year. Leo Pharma’s tralokinumab meets all primary and secondary endpoints in three pivotal Phase 3 studies for the treatment of adults with moderate-to-severe atopic derDrs. Rosen and Bhatia Highlight Latest Drugs at Maui Derm
https://reachmd.com/programs/practical-dermatology/drs-rosen-and-bhatia-highlight-latest-drugs-at-maui-derm/32914/The current landscape of therapeutics for dermatologic conditions is dramatic, with new groundbreaking drugs continuously becoming available.The Do’s and Don’ts of Managing Pediatric Hidradenitis Suppurativa
https://practicaldermatology.com/topics/rare-disease/the-dos-and-donts-of-managing-pediatric-hidradenitis-suppurativa/54450/Pediatric HS is often underrecognized, especially in prepubertal children, leading to delayed treatment and preventable disease progression. Clinicians should adapt diagnostic criteria and proactively screen high-risk groups, such as patients with severe acne. Children with HS frequently have assoc